Adam Andrzej Plich

Adam Andrzej Plich is the Founder & CEO of Avanzanite Bioscience, a company focused on improving patient access to orphan medicines. With a background in pharmaceuticals and market access, Adam has extensive experience in the industry, previously holding positions such as Vice President at Teva Pharmaceuticals and General Manager at Creativ-Ceutical. He is also the Managing Director of Plich Investments and Plich Advisory. Educated at the Medical University of Warsaw and INSEAD, Adam holds a Master of Science in Pharmacy and has completed the Accelerated PACE-Marketing for Specialty Brands Program.